acut
often
sever
respiratori
ill
emerg
southern
china
late
rapidli
spread
differ
area
far
east
well
sever
countri
around
globe
outbreak
appar
novel
infecti
diseas
term
sever
acut
respiratori
syndrom
sar
came
end
juli
caus
probabl
case
worldwid
death
start
march
world
health
organ
organis
unpreced
intern
effort
lead
laboratori
work
togeth
find
caus
agent
littl
one
week
later
three
research
group
whocoordin
network
simultan
found
evid
hitherto
unknown
coronaviru
sar
patient
use
differ
approach
koch
postul
fulfil
offici
declar
april
viru
never
seen
human
caus
sar
ever
sinc
progress
around
sarsassoci
coronaviru
sarscov
swift
within
week
first
isol
obtain
complet
genom
sequenc
diagnost
test
base
detect
sarscov
rna
develop
made
avail
freeli
wide
nevertheless
sar
case
definit
still
remain
base
clinic
epidemiolog
criteria
agent
environment
stabil
method
suitabl
inactiv
disinfect
potenti
antivir
compound
studi
develop
vaccin
immunotherapeut
ongo
despit
grave
consequ
humanitarian
polit
econom
term
sar
may
serv
exampl
much
achiev
wellcoordin
intern
approach
combin
latest
technolog
advanc
molecular
virolog
tradit
techniqu
carri
excel
standard
sever
acut
respiratori
syndrom
sar
latest
seri
emerg
infecti
diseas
certainli
one
wide
publicis
acut
often
sever
respiratori
ill
seem
emerg
southern
china
late
world
health
organ
soon
caus
consider
intern
alarm
sever
index
case
given
rise
outbreak
sometim
review
dedic
prepar
risk
live
provid
care
sar
patient
control
first
pandem
centuri
correspond
author
tel
fax
email
address
annemarieberg
emunifrankfurtd
berger
enorm
scale
diseas
abil
spread
distant
area
within
short
period
time
becam
obviou
world
health
organ
definit
develop
suspect
probabl
sar
case
base
clinic
epidemiolog
criteria
sinc
modifi
sever
occas
sar
demonstr
vividli
modern
world
enorm
volum
intercontinent
traffic
infecti
agent
may
spread
rapidli
across
globe
also
serv
exampl
modern
technologyprovid
necessari
determin
coordin
make
best
use
itmay
help
combat
threat
unpreced
speed
enorm
success
sar
character
clinic
fever
follow
respiratori
sign
symptom
may
lead
rapidli
progress
respiratori
failur
septemb
peopl
notifi
world
health
organ
fulfil
criteria
probabl
sar
die
sar
http
wwwwhointcsr
made
sarsin
contrast
eg
influenzanotori
propens
caus
hospit
outbreak
affect
peopl
includ
health
care
staff
patient
visitor
contrast
mani
emerg
viral
infect
ebola
hantaviru
pulmonari
syndrom
nipah
sar
also
clearli
demonstr
abil
easi
rapid
geograph
spread
sar
agent
affect
gener
rather
mobil
popul
infect
normal
remain
well
enough
travel
sever
day
onset
infect
march
set
worldwid
network
virolog
laboratori
investig
sar
case
world
health
organ
investig
conduct
member
network
coordin
depart
communic
diseas
surveil
respons
csr
normal
daili
telephon
confer
passwordprotect
internet
websit
thu
result
plan
studi
commun
view
comment
exchang
almost
realtim
made
possibl
rapid
progress
elucid
aetiolog
agent
final
form
network
compris
particip
laboratori
ten
countri
world
health
organ
multicentr
collabor
network
sever
acut
respiratori
syndrom
diagnosi
investig
soon
rule
novel
influenza
viru
strain
possibl
avian
origin
caus
sar
focuss
member
paramyxovirida
famili
includ
human
metapneumoviru
hmpv
chlamydialik
organ
includ
chlamydia
pneumonia
howev
investig
confirm
find
said
agent
inde
found
number
sar
patient
multicentr
collabor
network
sever
acut
respiratori
syndrom
sar
diagnosi
almost
nobodi
knew
stage
virologist
beij
alreadi
discov
new
viru
sampl
earliest
sar
patient
howev
offici
line
china
time
novel
atyp
pneumonia
caus
chlamydia
enserink
nevertheless
end
march
laboratori
hong
kong
germani
canada
unit
state
america
found
evid
novel
coronaviru
patient
sar
cell
cultur
electron
microscopi
polymeras
chain
reaction
pcr
use
primer
low
stringenc
design
agent
follow
sequenc
peiri
et
al
drosten
et
al
ksiazek
et
al
poutanen
et
al
drosten
et
al
result
could
rule
thorough
extens
test
chanc
led
discoveri
novel
agent
respons
new
ill
rather
innoc
bystand
howev
sequenc
obtain
differ
part
world
shown
belong
previous
unrecognis
coronaviru
ruan
et
al
could
also
shown
sar
patient
underw
seroconvers
coronaviru
use
cell
infect
patient
isol
antigen
indirect
immunofluoresc
antibodi
test
drosten
et
al
ksiazek
et
al
fig
furthermor
evid
present
past
infect
agent
could
detect
limit
survey
healthi
control
individu
suffer
sar
ksiazek
et
al
strengthen
case
novel
coronaviru
caus
sar
shown
caus
similar
ill
artifici
infect
macaqu
could
regard
fulfil
four
koch
postul
world
health
organis
multicentr
collabor
network
sever
acut
respiratori
syndrom
diagnosi
april
less
month
laboratori
network
brought
exist
offici
announc
new
coronaviru
never
seen
human
anim
provision
term
sarsassoci
coronaviru
abbrevi
sarscov
caus
sar
coronavirus
larg
envelop
positivestrand
rna
virus
diamet
nm
viral
particl
display
characterist
appear
surfac
project
give
rise
viru
famili
name
corona
latin
crown
largest
genom
rna
virus
base
uniqu
transcript
strategi
involv
format
nest
mrna
molecul
cavanagh
within
coronavirida
genera
toroviru
coronaviru
type
speci
infecti
bronchiti
viru
ibv
distinguish
uniqu
featur
coronaviru
genet
high
frequenc
rna
recombin
result
discontinu
transcript
polymeras
jump
lai
cavanagh
one
exampl
porcin
respiratori
coronaviru
prcov
evolv
earli
enteropathogen
porcin
transmiss
gastroenter
coronaviru
tgev
known
sinc
pensaert
et
al
larg
delet
gene
viru
acquir
alter
tissu
tropism
caus
mild
respiratori
infect
base
homolog
amino
acid
sequenc
level
known
coronavirus
divid
three
group
tabl
give
overview
coronaviru
speci
group
assign
host
speci
diseas
manifest
avail
vaccin
dozen
known
coronavirus
affect
differ
anim
speci
wherea
group
ii
coronavirus
affect
variou
mammal
group
iii
infect
bird
caus
major
problem
livestock
industri
may
affect
companion
anim
therefor
consider
effort
devot
control
includ
develop
activ
immunis
negativestain
transmiss
electron
microscopi
respiratori
sampl
sar
patient
infect
cell
cultur
supernat
reveal
pleomorph
envelop
viruslik
particl
diamet
nm
fig
viral
particl
show
characterist
coronaviruslik
surfac
featur
ksiazek
et
al
contrast
coronavirus
infect
cell
natur
host
speci
close
relat
speci
sarscov
abl
infect
differ
cell
cultur
african
green
monkey
cercopithecu
aethiop
kidney
cell
vero
human
colorect
adenocarcinoma
cell
line
caus
massiv
cytopath
effect
cpe
littl
day
day
fig
mention
cell
line
commonli
use
isol
human
respiratori
virus
interestingli
cell
cultur
passag
frankfurt
isol
viru
variant
emerg
nucleotid
delet
base
biolog
signific
find
remain
elucid
complet
genom
sequenc
sarscov
first
publish
canadian
laboratori
center
diseas
control
cdc
atlanta
marra
et
al
rota
et
al
endoctob
full
genom
sequenc
avail
http
wwwncbinlmnihgovgenom
sarssarshtml
genom
data
avail
far
sever
sarscov
strain
suggest
novel
agent
belong
known
group
coronavirus
fig
electron
microscopi
imag
sarscov
particl
infect
cell
cultur
supernat
ultracentrifug
formalin
fixat
neg
stain
uranyl
acet
photograph
h
r
gelderblom
robert
koch
institut
berlin
germani
includ
two
human
coronavirus
hcov
drosten
et
al
marra
et
al
peiri
et
al
rota
et
al
moder
relat
fig
sarscov
appear
neither
mutant
known
coronaviru
recombin
known
coronavirus
holm
propos
new
viru
defin
fourth
lineag
coronaviru
group
iv
marra
et
al
fig
howev
recent
suggest
sarscov
may
earli
splitoff
group
lineag
sequenc
analysi
sarscov
suggest
anim
viru
still
unknown
natur
host
speci
recent
develop
abil
product
infect
human
genet
close
ident
viru
found
wild
anim
mask
palm
civet
raccoon
dog
wildlif
market
guangdong
uncertainti
remain
exact
sourc
viru
anim
sampl
could
infect
human
anoth
anim
speci
cyranoski
abbott
normil
enserink
sequenc
analysi
differ
sarscov
isol
reveal
two
distinct
genotyp
one
genotyp
link
infect
origin
hotel
hong
kong
one
compris
isol
hong
kong
guangdong
beij
associ
hotel
ruan
et
al
tsui
et
al
date
inform
whether
differ
sarscov
strain
may
differ
degre
virul
littl
doubt
sar
origin
guangdong
provinc
southern
china
breiman
et
al
first
case
retrospect
identifi
sar
occur
novemb
interestingli
amongst
earli
case
seem
significantli
higher
percentag
food
handler
chef
etc
gener
popul
lend
support
zoonot
origin
worldwid
spread
sarscov
trigger
singl
infect
individu
guangdong
spent
time
hong
kong
succumb
sar
chanyeung
yu
time
unwittingli
infect
sever
other
turn
gave
rise
seri
outbreak
center
diseas
control
prevent
sometim
sever
gener
transmiss
event
carri
viru
differ
hong
kong
hospit
commun
well
vietnam
singapor
canada
unit
state
america
beyond
total
countri
area
world
world
health
organ
viru
travel
infect
human
pass
sever
gener
reflect
genet
related
isol
countri
although
china
late
admit
sarscov
unsurprisingli
also
spread
within
mainland
china
end
worst
affect
area
capit
beij
case
total
surpass
count
guangdong
far
world
health
organ
western
pacif
region
countri
offic
china
http
wwwwprowhointwrchnchn
sarsasp
incub
period
sar
short
rang
day
larg
studi
consist
note
median
incub
period
day
booth
et
al
lee
et
al
tsang
et
al
howev
time
exposur
onset
symptom
may
vari
consider
continu
conclud
current
best
estim
maximum
incub
period
day
updat
case
fatal
ratio
incub
period
http
base
latest
data
case
fatal
ratio
estim
person
age
year
younger
person
age
year
person
age
year
greater
person
age
year
older
updat
case
fatal
ratio
incub
period
http
wwwwhointcsrsar
pregnant
women
sar
appear
wors
prognosi
higher
mortal
therefor
earli
deliveri
termin
pregnanc
consid
serious
ill
sar
women
rel
well
sar
howev
seem
reason
elect
preterm
deliveri
reduc
risk
maternofet
transmiss
wong
et
al
compar
adult
teenag
sar
seem
take
less
aggress
clinic
cours
younger
children
hon
et
al
multivari
analysi
show
presenc
diabet
advanc
age
comorbid
condit
independ
associ
poor
outcom
booth
et
al
donnelli
et
al
fowler
et
al
present
time
new
casesapart
isol
laboratoryacquir
onehav
report
sinc
june
sarscov
appar
driven
human
popul
world
health
organ
meantim
issu
consensu
document
sar
epidemiolog
depart
communic
diseas
surveil
respons
pattern
geograph
spread
sar
similar
across
affect
area
typic
patient
sar
arriv
previous
affect
area
identifi
hospitalis
thu
infect
health
care
worker
patient
hospit
visitor
infect
close
contact
diseas
move
larger
commun
hawkey
et
al
viru
seem
spread
predominantli
respiratori
droplet
rel
close
distanc
howev
least
circumst
direct
indirect
contact
respiratori
secret
faec
anim
vector
may
also
lead
transmiss
hong
kong
depart
health
environment
health
team
tsang
et
al
ng
shed
sarscov
faec
urin
also
occur
signific
unknown
durat
infect
still
unclear
faecal
shed
seem
last
sever
week
howev
necessarili
mean
suffici
excret
infecti
viral
particl
infect
individu
peiri
et
al
practis
stringent
droplet
contact
precaut
significantli
reduc
risk
infect
exposur
patient
sar
therefor
protect
role
mask
suggest
main
rout
transmiss
droplet
sarscov
spread
effici
sophist
hospit
set
evid
suggest
certain
procedur
intub
difficult
circumst
use
nebul
increas
risk
infect
case
laboratoryacquir
sarscov
transmiss
far
occur
singapor
septemb
involv
postgradu
work
virolog
laboratori
subsequ
investig
show
inappropri
laboratori
standard
sever
acut
respiratori
syndrom
sar
singaporeupd
http
wwwwhointcsr
secondari
transmiss
aros
case
demonstr
need
optim
biosafeti
precaut
laboratori
work
sarscov
constitut
place
earth
sarscov
current
known
still
exist
might
sourc
reemerg
blood
transfus
administr
blood
product
implic
transmiss
anywher
despit
demonstr
viraemia
clinic
phase
ill
albeit
low
moder
titr
drosten
et
al
nevertheless
potenti
bloodborn
transmiss
led
earli
implement
measur
exclus
possibl
expos
individu
donor
pool
sarscov
moder
transmiss
singl
infecti
case
infect
three
secondari
case
lipsitch
et
al
riley
et
al
nevertheless
cluster
case
hotel
apart
build
hong
kong
show
transmiss
sarscov
extrem
effici
attack
rate
excess
report
one
common
observ
variou
area
occurr
socal
superspread
ie
individu
transmit
infect
least
ten
other
world
health
organ
superspread
mostli
ill
often
die
sar
invari
seriou
laps
infect
control
precaut
occur
manag
far
evid
differ
viru
strain
may
respons
superspread
phenomenon
also
firm
evid
suggest
subsequ
transmiss
led
clinic
less
sever
ill
possibl
attenu
viru
also
unclear
children
rel
underrepres
amongst
sar
case
averag
seem
suffer
less
sever
sar
ill
studi
stabil
new
sarscov
demonstr
viru
stabl
room
temperatur
previous
known
human
coronavirus
sizun
et
al
viru
shown
surviv
hour
plastic
surfac
day
diarrhoea
nevertheless
viru
lose
infect
exposur
differ
commonli
use
disinfect
fix
heat
exposur
c
quickli
reduc
infect
world
health
organ
first
data
stabil
resist
sarscov
compil
member
laboratori
network
avail
http
wwwwhointcsrsar
surviv
defin
person
suspect
sar
document
high
fever
c
plu
cough
breath
difficulti
contact
person
believ
sar
histori
travel
stay
geograph
area
document
transmiss
ill
occur
day
prior
onset
symptom
suspect
case
suspect
case
infiltr
consist
pneumonia
respiratori
distress
syndrom
rd
chest
xray
reclassifi
probabl
case
revis
case
definit
may
see
http
wwwwhointcsrsarscasedefinitionen
first
time
includ
virusspecif
laboratori
result
suspect
case
test
posit
sarscov
one
assay
also
reclassifi
probabl
recommend
issu
use
laboratori
method
sarscov
see
http
wwwwho
intcsrsarslabmethodsen
howev
present
defin
criteria
neg
sarscov
test
result
reject
diagnosi
sar
given
rather
low
shed
sarscov
upper
respiratori
tract
drosten
et
al
insuffici
sensit
present
avail
laboratori
method
prematur
exclus
basi
neg
test
result
may
lead
tragic
consequ
posit
laboratori
test
result
agent
abl
caus
atyp
pneumonia
may
serv
exclus
criteria
accord
case
definit
case
exclud
altern
diagnosi
fulli
explain
ill
nevertheless
possibl
dual
infect
must
rule
complet
requir
epidemiolog
linkag
repeatedli
proven
problemat
area
recognis
affect
import
case
fulfil
criteria
sar
becam
infect
local
contact
unrecognis
case
thu
preciou
time
may
lost
case
recognis
appropri
measur
taken
thorough
analysi
show
exist
criteria
lack
sensit
prehospit
set
rainer
et
al
may
problemat
may
delay
appropri
manag
sar
case
human
coronavirus
known
prior
march
difficult
propag
cell
cultur
diseas
associationsgener
mild
respiratori
ill
common
cold
enter
rare
possibl
neurolog
diseasel
widespread
neglect
medic
virolog
group
work
variou
scientif
aspect
laboratori
offer
routin
diagnost
test
mainli
pcr
sarscov
hand
readili
propag
vitro
may
also
detect
pcr
indirectli
antibodi
test
nevertheless
despit
consider
progress
field
much
remain
done
laboratori
test
becom
use
tool
manag
sar
case
world
health
organ
multicentr
collabor
network
sever
acut
respiratori
syndrom
diagnosi
presenc
infecti
viru
detect
inocul
suitabl
cell
cultur
eg
vero
cell
patient
specimen
respiratori
secret
blood
stool
propag
viru
vitro
isol
viru
must
identifi
sarscov
use
test
accord
intern
consensu
work
perform
biosafeti
level
bsl
three
condit
sarscovspecif
rna
amplifi
variou
clinic
specimen
especi
respiratori
secret
stool
pcr
high
concentr
viral
rna
million
molecul
per
millilitr
found
sputum
viral
rna
also
detect
albeit
extrem
low
concentr
plasma
acut
phase
faec
late
convalesc
phase
suggest
viru
may
shed
faec
prolong
period
time
drosten
et
al
commerci
realtim
rtpcr
test
kit
contain
primer
posit
neg
control
develop
bernhard
nocht
institut
http
wwwbnihamburgd
avail
http
wwwartusbiotechd
inactiv
standard
prepar
also
avail
diagnost
purpos
european
network
import
viral
infect
enivd
http
wwwenivdd
enivd
also
prepar
intern
extern
qualiti
assess
scheme
sarscov
assay
exist
pcr
test
rule
certainti
presenc
sarscov
patient
hand
contamin
sampl
laboratori
perform
pcr
may
lead
falseposit
result
unless
appropri
precaut
taken
variou
method
develop
detect
antibodi
produc
respons
infect
sarscov
probabl
virtual
patient
first
type
antibodi
test
employ
immunofluoresc
assay
ifa
use
cell
infect
patient
viru
isol
antihuman
igg
fitc
conjug
abl
demonstr
specif
seroconvers
two
frankfurt
sar
patient
drosten
et
al
fig
enzymelink
immunosorb
assay
elisa
develop
detect
antibodi
serum
sar
patient
reliabl
yield
posit
result
around
day
onset
ill
world
health
organ
multicentr
collabor
network
sever
acut
respiratori
syndrom
diagnosi
neutralis
test
nt
assess
quantifi
mean
titrat
abil
patient
sera
neutralis
infect
sarscov
cell
cultur
nt
titr
may
therefor
correl
clinic
immun
although
yet
demonstr
howev
nt
limit
institut
facil
antibodi
test
commerci
avail
far
ifa
yield
posit
result
day
onset
ill
euroimmun
germani
diagnosi
sar
base
entir
set
clinic
epidemiolog
criteria
far
report
case
number
like
includ
substanti
number
nonsar
patient
therefor
recov
patient
test
systemat
specif
sarscov
antibodi
reactiv
confirm
diagnos
retrospect
thu
allow
better
understand
epidemiolog
featur
although
electron
microscopi
import
role
rapid
diagnosi
infecti
agent
emerg
situat
hazelton
gelderblom
provid
circumstanti
evid
case
sar
viruslik
agent
first
visualis
clinic
materi
sar
case
electron
microscopi
classif
ambigu
later
turn
human
metapneumoviru
poutanen
et
al
even
case
coronaviruslik
particl
detect
could
distinguish
classic
human
coronavirus
specif
treatment
recommend
made
time
primari
measur
includ
isol
implement
stringent
infect
control
measur
effect
prevent
transmiss
empir
therapi
includ
coverag
organ
associ
communityacquir
pneumonia
unclear
aetiolog
includ
agent
activ
typic
atyp
respiratori
pathogen
treatment
choic
may
influenc
sever
ill
oxygen
supplement
often
necessari
sever
case
seem
better
intens
care
includ
artifici
respir
commenc
earli
et
al
effort
underway
variou
institut
assess
potenti
antisarscov
agent
vitro
ribavirin
broad
spectrum
agent
activ
variou
rna
virus
also
use
clinic
sar
patient
koren
et
al
seem
lack
vitro
effect
cinatl
et
al
corticosteroid
wide
use
sar
patient
particularli
china
rational
administr
observ
tissu
chang
suggest
part
lung
damag
due
cytokin
induc
viru
peiri
et
al
clinic
report
also
underlin
use
zhao
et
al
therapi
explor
convalesc
plasma
wong
et
al
normal
human
immunoglobulin
may
benefici
immunomodulatori
effect
act
agent
caus
secondari
infect
preliminari
clinic
data
suggest
proteas
inhibitor
use
antihiv
therapi
lopinavir
nelfinavir
yamamoto
n
person
commun
might
efficaci
initi
therapi
rescu
set
hong
kong
research
report
global
confer
sar
kuala
lumpur
june
sar
patient
treat
kaletra
lopinavir
lowdos
ritonavir
plu
ribavirin
experienc
reduct
death
rate
effort
underway
develop
target
antisarscov
approach
broad
screen
avail
substanc
vitro
led
potenti
import
clue
recent
glycyrrhizin
compound
found
liquoric
root
glycyrrhiza
glabra
l
report
good
vitro
activ
sarscov
cinatl
et
al
mechan
glycyrrhizin
activ
sarscov
unclear
glycyrrhizin
previous
use
treat
patient
chronic
hepat
c
viru
interestingli
compound
may
contain
herbal
prepar
wide
use
sar
patient
china
part
tradit
chines
medicin
lin
et
al
furthermor
interferon
inhibit
sarscov
vitro
recent
studi
cinatl
et
al
interferon
potent
interferon
therefor
could
becom
drug
choic
futur
alon
combin
antivir
drug
rapid
success
identifi
caus
agent
sar
result
collabor
effortrath
competit
approachbi
highlevel
laboratori
investig
make
use
avail
techniqu
cell
cultur
electron
microscopi
hazelton
gelderblom
molecular
techniqu
order
identifi
novel
agent
hope
approach
coordin
serv
model
futur
instanc
emerg
infect
undoubtedli
take
place
ludwig
et
al
despit
exemplari
effort
led
identif
caus
novel
coronaviru
allow
enorm
knowledg
accumul
within
month
mayb
surpris
success
termin
outbreak
attribut
oldfashion
measur
rapid
strict
isol
suspect
case
thorough
contact
trace
world
health
organ
one
left
wonder
whether
might
also
achiev
without
knowledg
aetiolog
thank
intern
wellcoordin
case
time
determin
respons
new
case
sar
notifi
sinc
june
sever
countri
report
sar
case
import
area
report
outbreak
experi
secondari
transmiss
likewis
vietnam
first
countri
demonstr
thatthrough
combin
earli
detect
public
alert
follow
decis
public
health
action
often
heroic
effort
individualsfurth
transmiss
could
curtail
reilley
et
al
absenc
new
clinic
case
worldwid
suggest
sarscov
longer
circul
within
human
popul
howev
possibl
clinic
silent
infect
longterm
viru
carrier
rule
complet
furthermor
origin
agent
remain
obscur
sarscov
close
relat
viru
persist
hitherto
unidentifi
anim
reservoir
may
yet
cross
speci
barrier
lead
human
outbreak
numer
question
relat
epidemiolog
sar
yet
answer
normil
enserink
breiman
et
al
time
write
octob
complet
uncertain
whether
sar
ever
reappear
unclear
whether
season
recurr
may
occur
southern
china
unlik
europ
north
america
annual
influenza
peak
incid
march
juli
huang
et
al
thu
show
similar
epidem
curv
sar
outbreak
enserink
advent
next
flu
season
pose
consider
problem
given
lack
reliabl
laboratori
method
earli
diagnosi
sar
case
definit
need
adjust
world
without
sar
theori
new
case
imposs
criterion
epidemiolog
link
fulfil
preciou
time
may
therefor
lost
reappear
detect
vigil
sar
must
clearli
maintain
see
alert
verif
public
health
manag
sar
postoutbreak
august
continu
vigil
sar
http
wwwwhointcsrsarspostoutbreak
en
purpos
defin
three
geograph
zone
accord
presum
risk
sar
recurr
potenti
zone
reemerg
compris
guangdong
area
animaltohuman
sarscov
might
occur
nodal
area
compris
hong
kong
vietnam
singapor
canada
taiwan
sustain
local
transmiss
spring
entri
numer
person
potenti
zone
reemerg
low
risk
area
sarsrel
vigil
stage
accord
zone
particular
area
situat
low
risk
area
surveil
cluster
alert
case
among
health
care
worker
hospit
staff
patient
visitor
health
care
unit
sar
alert
defin
two
health
care
worker
hospitalacquir
ill
least
three
individu
health
care
worker
andor
hospit
staff
andor
patient
andor
visitor
unit
fulfil
clinic
case
definit
sar
onset
ill
period
zone
supplement
enhanc
surveil
plu
special
studi
sarscov
infect
anim
human
popul
potenti
zone
reemerg
besid
improv
exist
detect
assaysfor
instanc
pcr
method
base
amplif
nucleoprotein
gene
may
intrins
sensit
due
coronavir
transcript
strategi
thu
valuabl
earli
diagnosisfurth
laboratori
research
need
includ
detail
physicochem
analysi
sarscov
protein
allow
develop
novel
compound
base
target
drug
design
anand
et
al
although
effect
vaccin
expect
avail
soon
rel
eas
sarscov
propag
vitro
clearli
help
suitabl
anim
model
sar
may
avail
form
cynomolgu
macaqu
macaca
fasciculari
avail
vaccin
anim
coronavirus
avian
infecti
bronchiti
viru
transmiss
gastroenter
coronaviru
pig
felin
infecti
periton
viru
encourag
obviou
lack
protect
immun
human
infect
hcov
also
current
commerci
veterinari
vaccin
prevent
respiratori
coronaviru
infect
except
infecti
bronchiti
viru
infect
chicken
research
also
urgent
need
determin
whether
immun
pathogenesi
play
sar
whether
immun
enhanc
may
occur
chanc
develop
effect
safe
vaccin
therefor
remain
uncertain
hope
encourag
start
atmospher
open
collabor
mutual
trust
progress
sarscov
research
imped
patent
matter
gold
